trending Market Intelligence /marketintelligence/en/news-insights/trending/HfzW7do-bIYIS3vXUR7P9w2 content esgSubNav
In This List

Sweden's Elekta gains US FDA approval for diffusion-weighted images

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sweden's Elekta gains US FDA approval for diffusion-weighted images

Elekta AB (publ) said the U.S. Food and Drug Administration approved the use of Elekta Unity in diffusion-weighted imaging.

The FDA clearance allows diffusion-weighted images derived using Elekta Unity to be interpreted by trained physicians.

Diffusion-weighted imaging is a technique that uses the motion of water molecules to create contrast in magnetic resonance images.

The Stockholm-based company's Elekta Unity technology allows doctors to better target cancers and allows for personalized radiation therapy regimens.